Survey of Physicians’ Understanding of Specific Risks Associated with Retigabine
Crossref DOI link: https://doi.org/10.1007/s40801-016-0068-3
Published Online: 2016-05-04
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Daniluk, Jerzy
Cooper, James A.
Stender, Monika
Kowalczyk, Anna
Funding for this research was provided by:
GlaxoSmithKline
License valid from 2016-05-04